RU2658487C2 - Получение вирусного вектора - Google Patents
Получение вирусного вектора Download PDFInfo
- Publication number
- RU2658487C2 RU2658487C2 RU2016121425A RU2016121425A RU2658487C2 RU 2658487 C2 RU2658487 C2 RU 2658487C2 RU 2016121425 A RU2016121425 A RU 2016121425A RU 2016121425 A RU2016121425 A RU 2016121425A RU 2658487 C2 RU2658487 C2 RU 2658487C2
- Authority
- RU
- Russia
- Prior art keywords
- virus
- cells
- cell
- cho
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24151—Methods of production or purification of viral material
- C12N2710/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013904242 | 2013-11-01 | ||
| AU2013904242A AU2013904242A0 (en) | 2013-11-01 | Viral vector manufacture | |
| AU2014900370 | 2014-02-07 | ||
| AU2014900370A AU2014900370A0 (en) | 2014-02-07 | Orthopox vectors and propagation | |
| PCT/AU2014/050330 WO2015061858A1 (en) | 2013-11-01 | 2014-11-03 | Viral vector manufacture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2016121425A RU2016121425A (ru) | 2017-12-04 |
| RU2658487C2 true RU2658487C2 (ru) | 2018-06-21 |
Family
ID=53003022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016121425A RU2658487C2 (ru) | 2013-11-01 | 2014-11-03 | Получение вирусного вектора |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10544397B2 (https=) |
| EP (2) | EP3375882B1 (https=) |
| JP (2) | JP6682443B2 (https=) |
| KR (1) | KR102047030B1 (https=) |
| CN (1) | CN106255758B (https=) |
| AU (1) | AU2014344738B2 (https=) |
| CA (1) | CA2931518C (https=) |
| CY (1) | CY1121414T1 (https=) |
| DK (2) | DK3063278T3 (https=) |
| ES (1) | ES2670034T3 (https=) |
| HR (1) | HRP20180789T1 (https=) |
| HU (1) | HUE037718T2 (https=) |
| IL (1) | IL245363B (https=) |
| LT (1) | LT3063278T (https=) |
| NO (1) | NO3063278T3 (https=) |
| NZ (1) | NZ720241A (https=) |
| PL (1) | PL3063278T3 (https=) |
| PT (1) | PT3063278T (https=) |
| RS (1) | RS57290B1 (https=) |
| RU (1) | RU2658487C2 (https=) |
| SG (1) | SG11201603919XA (https=) |
| SI (1) | SI3063278T1 (https=) |
| SM (1) | SMT201800267T1 (https=) |
| TR (1) | TR201807128T4 (https=) |
| WO (1) | WO2015061858A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL264893B (en) * | 2016-08-19 | 2022-08-01 | Sementis Ltd | Vaccines for viruses |
| JP2018081568A (ja) * | 2016-11-17 | 2018-05-24 | グローリー株式会社 | 紙幣収納装置および紙幣処理機 |
| IL295154A (en) * | 2020-01-28 | 2022-09-01 | Lonza Walkersville Inc | Methods for determining viral titer |
| EP4547689A1 (en) * | 2022-06-30 | 2025-05-07 | Bavarian Nordic A/S | Mammalian cell line for the production of modified vaccinia virus ankara (mva) |
| WO2024064608A2 (en) * | 2022-09-20 | 2024-03-28 | Intergalactic Therapeutics, Inc. | Best1 vectors and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830688A (en) * | 1986-09-23 | 1998-11-03 | Transgene, S.A. | DNA sequences, vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of muliplying in CHO cells |
| RU2457253C2 (ru) * | 2005-04-11 | 2012-07-27 | Вивалис | Способ репликации вируса в птичьих эмбриональных стволовых клетках |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE298370T1 (de) | 1994-04-29 | 2005-07-15 | Baxter Healthcare Sa | Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen |
| WO2004015118A1 (en) * | 2002-08-07 | 2004-02-19 | Bavarian Nordic A/S | Vaccinia virus host range genes to increase the titer of avipoxviruses |
| CA2658301A1 (en) * | 2006-08-04 | 2008-02-07 | Dublin City University | A method of producing recombinant biological products |
-
2014
- 2014-11-03 RS RS20180588A patent/RS57290B1/sr unknown
- 2014-11-03 NO NO14858802A patent/NO3063278T3/no unknown
- 2014-11-03 SI SI201430731T patent/SI3063278T1/sl unknown
- 2014-11-03 DK DK14858802.3T patent/DK3063278T3/en active
- 2014-11-03 EP EP18154084.0A patent/EP3375882B1/en active Active
- 2014-11-03 PL PL14858802T patent/PL3063278T3/pl unknown
- 2014-11-03 HU HUE14858802A patent/HUE037718T2/hu unknown
- 2014-11-03 RU RU2016121425A patent/RU2658487C2/ru active
- 2014-11-03 US US15/033,541 patent/US10544397B2/en active Active
- 2014-11-03 JP JP2016550897A patent/JP6682443B2/ja active Active
- 2014-11-03 KR KR1020167014693A patent/KR102047030B1/ko active Active
- 2014-11-03 DK DK18154084.0T patent/DK3375882T3/da active
- 2014-11-03 NZ NZ72024114A patent/NZ720241A/en unknown
- 2014-11-03 HR HRP20180789TT patent/HRP20180789T1/hr unknown
- 2014-11-03 ES ES14858802.3T patent/ES2670034T3/es active Active
- 2014-11-03 WO PCT/AU2014/050330 patent/WO2015061858A1/en not_active Ceased
- 2014-11-03 LT LTEP14858802.3T patent/LT3063278T/lt unknown
- 2014-11-03 PT PT148588023T patent/PT3063278T/pt unknown
- 2014-11-03 EP EP14858802.3A patent/EP3063278B1/en active Active
- 2014-11-03 TR TR2018/07128T patent/TR201807128T4/tr unknown
- 2014-11-03 SG SG11201603919XA patent/SG11201603919XA/en unknown
- 2014-11-03 AU AU2014344738A patent/AU2014344738B2/en active Active
- 2014-11-03 CA CA2931518A patent/CA2931518C/en active Active
- 2014-11-03 CN CN201480071836.9A patent/CN106255758B/zh active Active
- 2014-11-03 SM SM20180267T patent/SMT201800267T1/it unknown
-
2016
- 2016-05-01 IL IL245363A patent/IL245363B/en active IP Right Grant
-
2018
- 2018-05-22 CY CY20181100533T patent/CY1121414T1/el unknown
-
2019
- 2019-10-18 JP JP2019191435A patent/JP2020039340A/ja active Pending
- 2019-12-11 US US16/711,184 patent/US20200190482A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830688A (en) * | 1986-09-23 | 1998-11-03 | Transgene, S.A. | DNA sequences, vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of muliplying in CHO cells |
| RU2457253C2 (ru) * | 2005-04-11 | 2012-07-27 | Вивалис | Способ репликации вируса в птичьих эмбриональных стволовых клетках |
Non-Patent Citations (4)
| Title |
|---|
| HSIAO J.C. et al, A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells, Journal of Virology, 08.2006, Vol.80, 15, 7714-7728. * |
| RAMSEY-EWING A.L. et al, Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene, Virology, 01.08.1996, Vol.222, 1, 75-86. * |
| SCHUENADEL L. et al, Generation and characterization of a Cowpox virus mutant lacking host range factor CP77, Virus Research, 13.06.2012, 168, 23-32. * |
| SCHUENADEL L. et al, Generation and characterization of a Cowpox virus mutant lacking host range factor CP77, Virus Research, 13.06.2012, 168, 23-32. HSIAO J.C. et al, A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells, Journal of Virology, 08.2006, Vol.80, 15, 7714-7728. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019377141B2 (en) | Enhanced systems for cell-mediated oncolytic viral therapy | |
| JP2020039340A (ja) | ウイルスベクターの作製 | |
| KR20170048396A (ko) | 재조합 변형된 백시니아 바이러스 앙카라 (mva) 필로바이러스 백신 | |
| KR20230034933A (ko) | Covid-19에 대한 보호를 위한 약독화된 폭스바이러스 벡터 기반 백신 | |
| CN112739359A (zh) | Apmv及其用于治疗癌症的用途 | |
| US20210113684A1 (en) | Vector-based attenuated poxvirus vaccines | |
| CN105039268A (zh) | 表达鸭坦布苏病毒e蛋白的重组鸭瘟病毒及其构建方法和应用 | |
| CN116144704A (zh) | 制备新型冠状病毒的病毒样颗粒的载体系统及方法 | |
| HK1260426B (en) | Viral vector manufacture | |
| HK1260426A1 (en) | Viral vector manufacture | |
| HK1223395B (en) | Viral vector manufacture | |
| RU2778312C2 (ru) | Вирусные вакцины | |
| CN102851293B (zh) | 靶向抑制羊痘病毒ORF095基因的序列siRNA-165 | |
| CA3088646A1 (en) | Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom |